Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Opioids can be defined as a class of drugs, which include the drug heroin, synthetic opioids such as fentanyl, and various pain relievers prescribed legally, such as oxycodone, hydrocodone, and others. This class of drug is primarily taken for pain relief. It has been used for other medical purposes including cough and diarrhea treatment. They bind to opioids receptor and produce a desirable result. Opioids are generally safe when taken for a short time, regular use of the drug can lead to dependence and in extreme cases may even result in death.
Market Dynamics
According to the National Institutes of Health (NIH) estimates, in 2015 by the American Pain Society, nearly 50 million people in the U.S. suffered from chronic pain. Use of opioids in cancer, orthopedic, neuropathic, post-operative pain, and lower back pain is very effective. With growing incidence of chronic pain demand for opioids is also expected to increase consequently. Moreover, opioid overdose or abuse has fueled the growth of the U.S. opioids market. CVS Health’s, leading pharmacy chain, reports that company had been often asked to fill the prescription of 30 to 60 of the powerful pills at a time for conditions that required a much more limited amount.
However, in near future, the overuse or abuse is expected to come down significantly with deceleration of opioids a public health emergency in October 2017 by U.S government. The pharmacy chain, insurance companies, doctors, and all professionals related (directly or indirectly) to this crisis are being monitored closely and had been asked to co-operate to end this epidemic. This strict government intervention are restraining the growth of the U.S. opioids market.
Key features of the study:
This report provides in-depth analysis of the U.S. opioids market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the U.S. opioids market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Purdue Pharma L.P., Titan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Janssen Pharmaceuticals, Inc., Sanofi S.A., Sun Pharmaceuticals Industries Limited, Mallinckrodt Pharmaceuticals, Egalet Corporation, Endo Pharmaceuticals plc, Allergan, Plc., and Pfizer Inc.
Insights from this report will allow marketers and the management authorities of companies to make informed decision with respect to their future product launch, market expansion, and marketing tactics
The U.S. opioids market report caters to various stakeholders in this industry, including investors, opioid manufacturers, distributors and suppliers, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the U.S. opioids market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
U.S. Opioids Market, By Drugs
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
U.S. Opioids Market, By Therapeutic Application:
Pain Management
Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others
Cough Treatment
Diarrhea Treatment
Company Profiles
Purdue Pharma L.P.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans
Titan Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Janssen Pharmaceuticals, Inc.
Sanofi S.A.
Sun Pharmaceuticals Industries Limited
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals plc
Allergan, Plc
Pfizer Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Drugs
? Market Snippet By Therapeutic Application
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Regulatory Scenario
o Reimbursement Scenario
o Industry Trend
o Mergers and Acquisitions
o PEST Analysis
o Government Policies and Initiatives
4. U.S. Opioids Market, By Drugs, 2014 - 2024 (USD Million & No. of Units)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Codeine
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
o Fentanyl
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
o Meperidine
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
o Methadone
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
o Morphine
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
o Hydrocodone
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
5. U.S. Opioids Market, By Therapeutic Application, 2014 - 2024 (USD Million & No. of Units)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Pain Management
? Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
• Neuropathic Pain
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
• Migraine
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
• Back Pain
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
• Osteoarthritis Pain
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
• Cancer Pain
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
• Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
o Cough Treatment
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
o Diarrhea Treatment
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & No. of Units)
6. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Purdue Pharma L.P.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
? Titan Pharmaceuticals, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
? Boehringer Ingelheim GmbH
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
? Janssen Pharmaceuticals, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
? Sanofi S.A.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
? Mallinckrodt Pharmaceuticals
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
? Egalet Corporation
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
? Endo Pharmaceuticals plc
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
? Allergan, Plc
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
? Pfizer Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
? Sun Pharmaceutical Industries Limited
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
7. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 11 market data tables and 19 figures on "Opioids Market - U.S. forecast to 2024".
